当前位置: »论坛 › 科研专区 › 文献互助› Comparison of Recombinant Human Thyroid-Stimulating ...

[ovid] Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer

求助已关闭

xxyao 发表于 3 天前 | 显示全部楼层 |阅读模式

悬赏10积分

期刊：Clinical Nuclear Medicine

文献作者：Sohyun Park; Ji-In Bang; Keunyoung Kim; Youngduk Seo; Ari Chong; Chae Moon Hong; Dong-Eun Lee; Miyoung Choi; Sang-Woo Lee; So Won Oh

出版日期：2024-3-

DOI号：10.1097/rlu.0000000000005022

下载链接：https://journals.lww.com/10.1097/RLU.0000000000005022

文献链接：https://doi.org/10.1097/rlu.0000000000005022

当前文献来源于 Ovid Technologies (Wolters Kluwer Health)。

备注信息：

使用道具捐赠获取积分应助有误反馈

全部回复0 显示全部楼层

发表回复

xxyao Lv.2

注册会员

发布
回复
积分
280

[ovid] Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ovid] Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer 一键复制

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ovid] Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer